Published in Clin Infect Dis on February 01, 2007
Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev (2010) 9.82
Trimethoprim-Sulfamethoxazole versus Placebo for Uncomplicated Skin Abscess. N Engl J Med (2016) 3.28
Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev (2015) 1.94
Randomized controlled trial of cephalexin versus clindamycin for uncomplicated pediatric skin infections. Pediatrics (2011) 1.58
Community-associated methicillin-resistant Staphylococcus aureus: trends in case and isolate characteristics from six years of prospective surveillance. Public Health Rep (2009) 1.35
To treat or not to treat: adjunctive antibiotics for uncomplicated abscesses. Ann Emerg Med (2011) 1.17
Methicillin-susceptible, non-multiresistant methicillin-resistant and multiresistant methicillin-resistant Staphylococcus aureus infections: a clinical, epidemiological and microbiological comparative study. Eur J Clin Microbiol Infect Dis (2008) 1.16
Epidemiology and outcomes of complicated skin and soft tissue infections in hospitalized patients. J Clin Microbiol (2011) 1.09
Prevalence, severity, and treatment of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) skin and soft tissue infections in 10 medical clinics in Texas: a South Texas Ambulatory Research Network (STARNet) study. J Am Board Fam Med (2011) 0.98
The increasing problem of wound bacterial burden and infection in acute and chronic soft-tissue wounds caused by methicillin-resistant Staphylococcus aureus. J Burns Wounds (2007) 0.95
Trends in prescribing beta-lactam antibiotics for treatment of community-associated methicillin-resistant Staphylococcus aureus infections. J Clin Microbiol (2007) 0.94
A new strategy to fight antimicrobial resistance: the revival of old antibiotics. Front Microbiol (2014) 0.94
Tetracyclines as an oral treatment option for patients with community onset skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2007) 0.92
The role of ancillary antimicrobial therapy for treatment of uncomplicated skin infections in the era of community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis (2007) 0.87
Methicillin-resistant Staphylococcus aureus in HIV-infected patients. Infect Drug Resist (2010) 0.86
Community acquired MRSA in Europe. BMJ (2007) 0.84
Resistance and the management of complicated skin and skin structure infections: the role of ceftobiprole. Ther Clin Risk Manag (2010) 0.83
"Ten Commandments" for the Appropriate use of Antibiotics by the Practicing Physician in an Outpatient Setting. Front Microbiol (2011) 0.81
World Society of Emergency Surgery (WSES) guidelines for management of skin and soft tissue infections. World J Emerg Surg (2014) 0.81
Skin and soft-tissue infections in suburban primary care: epidemiology of methicillin-resistant Staphylococcus aureus and observations on abscess management. BMC Res Notes (2011) 0.80
Clinical management of skin and soft tissue infections in the U.S. Emergency Departments. West J Emerg Med (2014) 0.80
Appropriateness of antibiotic management of uncomplicated skin and soft tissue infections in hospitalized adult patients. BMC Infect Dis (2016) 0.80
Antibiotic selection for purulent skin and soft-tissue infections in ambulatory care: a decision-analytic approach. Acad Pediatr (2009) 0.80
A study of the prevalence of methicillin-resistant Staphylococcus aureus in dermatology inpatients. Indian Dermatol Online J (2014) 0.78
Prevalence of methicillin resistant Staphylococcus aureus in upper extremity soft tissue infections at Jackson Memorial Hospital, Miami-Dade County, Florida. Iowa Orthop J (2009) 0.78
Risk factors for community-associated methicillin-resistant Staphylococcus aureus cellulitis--and the value of recognition. Hawaii Med J (2010) 0.77
Dose of trimethoprim-sulfamethoxazole to treat skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2011) 0.76
Evidence based approach to the treatment of community-associated methicillin-resistant Staphylococcus aureus. Infect Drug Resist (2009) 0.75
Treatment outcome measures for randomized controlled trials of antibiotic treatment for acute bacterial skin and skin structure infections in the emergency department setting. Int J Emerg Med (2015) 0.75
Community-Associated Methicillin-Resistant Staphylococcus aureus in the Pediatric Population. J Pediatr Pharmacol Ther (2008) 0.75
Detection of Methicillin-Resistant Coagulase-Negative Staphylococci and Surveillance of Antibacterial Resistance in a Multi-Center Study from Iran. Jundishapur J Microbiol (2015) 0.75
Staphylococcus aureus antimicrobial susceptibility of abscess samples from adults and children from the Kaleida Health System in western New York State, 2003 to 2006. J Clin Microbiol (2010) 0.75
MRSA Infections in HIV-Infected People Are Associated with Decreased MRSA-Specific Th1 Immunity. PLoS Pathog (2016) 0.75
Management of acute bacterial skin and skin structure infections with a focus on patients at high risk of treatment failure. Ther Adv Infect Dis (2017) 0.75
Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients. Clin Infect Dis (2010) 4.28
A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects. Clin Infect Dis (2003) 2.84
Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis (2008) 2.35
Blastomycosis of the central nervous system: a multicenter review of diagnosis and treatment in the modern era. Clin Infect Dis (2010) 1.16
Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections: case series and review of the literature. Clin Infect Dis (2005) 1.08
Salvage treatment of histoplasmosis with posaconazole. J Infect (2006) 1.04
Fatal spotted fever rickettsiosis, Kenya. Emerg Infect Dis (2004) 1.01
Blastomyces dermatitidis antigen detection by quantitative enzyme immunoassay. Clin Vaccine Immunol (2011) 1.00
An observational cohort comparison of facilitators of retention in care and adherence to anti-eetroviral therapy at an HIV treatment center in Kenya. PLoS One (2012) 0.98
Detection of Blastomyces dermatitidis antigen in patients with newly diagnosed blastomycosis. Diagn Microbiol Infect Dis (2011) 0.96
Tetracyclines as an oral treatment option for patients with community onset skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2007) 0.92
The use of pill counts as a facilitator of adherence with antiretroviral therapy in resource limited settings. PLoS One (2013) 0.87
A model for reduced HIV-1 viral load monitoring in resource-limited settings. J Int Assoc Provid AIDS Care (2012) 0.83
The endemic mimic: blastomycosis an illness often misdiagnosed. Trans Am Clin Climatol Assoc (2014) 0.80
Cerebral histoplasmosis in the azole era: report of four cases and review. South Med J (2003) 0.79
Multiple-serotype salmonella outbreaks in two state prisons--Arkansas, August 2012. MMWR Morb Mortal Wkly Rep (2014) 0.78
Histoplasmosis associated with a bamboo bonfire--Arkansas, October 2011. MMWR Morb Mortal Wkly Rep (2014) 0.78
Cardiac tamponade: an unusual complication of simultaneous treatment of tuberculosis and HIV. South Med J (2008) 0.78
A quality assessment tool for tuberculosis control activities in resource limited settings. Tuberculosis (Edinb) (2011) 0.77
Comparison of biochemical recurrence-free survival between periprostatic and pelvic lymph node metastases of prostate cancer. Int J Surg Pathol (2013) 0.75
The State of Public Health in Arkansas in 2015. J Ark Med Soc (2016) 0.75
Clarithromycin-nifedipine-induced acute kidney injury. Nurse Pract (2017) 0.75
Tularemia induced bilateral optic neuritis. J Ark Med Soc (2006) 0.75
Newborn screening improvements in Arkansas. J Ark Med Soc (2015) 0.75
Public health in Arkansas--where are we now? J Ark Med Soc (2014) 0.75
Use of DNA fingerprinting in decision making for considering closure of neonatal intensive care units because of Pseudomonas aeruginosa bloodstream infections. Pediatr Infect Dis J (2004) 0.75
Arkansas Department of Health--report on activities. J Ark Med Soc (2015) 0.75
Treatment of endemic mycoses. Expert Rev Respir Med (2010) 0.75
A clinical review of Lyme disease in Arkansas. J Ark Med Soc (2010) 0.75